Indegene Gets 'Add' Rating As ICICI Securities Initiates Coverage

NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

ICICI Securities Report

Indegene Ltd., a digital-first life sciences commercialisation company, enables biopharmaceutical (biopharma) players to launch and scale products with speed, precision and efficiency.

Indegene’s business moat is fortified by:

1. its longstanding marquee client relationships (global top-20 pharma companies account for 64% of revenue);

2. premium positioning vs. IT services peers, given its specialised higher value services; and

3. its track record of systematic and consistent organic (12%+ workforce dedicated for next generation technology) as well as inorganic investments (13+ acquisitions).

Indigene’s distinct positioning in AI-enabled solutions, diversified service portfolio and consistent execution provide visibility for sustainable double-digit earnings growth.

We initiate coverage on Indegene with an Add rating, balancing near-term valuation comfort and strong medium-term growth potential.

We model 11%/15% USD revenue/PAT CAGRs over FY25–28E. We assign a 26x target multiple (1 SD below lifetime avg. P/E) on Sep’27E-ending EPS of Rs 24 to arrive at a target price of Rs 630.

Key risk: Any future client-specific issues.

Click on the attachment to read the full report:

DISCLAIMER

This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.